Loading...
Market
Market share impact on Dynacare by end of 2024 due to recall?
1
Resolution / Starting Odds
No change • 25%
Decrease by less than 10% • 25%
Decrease by 10-20% • 25%
Decrease by more than 20% • 25%
Market analysis reports, sales data, and financial statements
Story
FDA Expands Dynacare Baby Powder Recall to 1,020 Cases Sold Since January in 35 States Due to Asbestos
Oct 29, 2024, 10:00 PM
The U.S. Food and Drug Administration (FDA) has expanded a nationwide recall of Dynacare Baby Powder due to potential asbestos contamination. The recall has been broadened from an initial 62 cases in 12 states to encompass 1,020 cases across 35 states. The affected products were sold on or after January 18, 2024, both in stores and online, including through Amazon. Routine testing by the FDA detected the presence of asbestos, a known carcinogen linked to serious health risks, including cancer, in the baby powder products. Consumers who have purchased Dynacare Baby Powder are advised to discontinue use immediately and follow the FDA's instructions for returning or disposing of the product.
View original story
Similar markets
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
More than $1 billion • 25%
Increases • 25%
Remains stable • 25%
Decreases slightly • 25%
Decreases significantly • 25%
Increase • 25%
Decrease • 25%
Remain the same • 25%
Other • 25%
Market share increases • 25%
Market share remains the same • 25%
Market share decreases • 25%
Foresight exits cancer-detection market • 25%
Increase by 5% or more • 33%
Fluctuate within ±5% • 33%
Decrease by 5% or more • 33%
Sales increase • 25%
Sales remain the same • 25%
Sales decrease by less than 20% • 25%
Sales decrease by more than 20% • 25%
No significant impact (less than 1% change) • 25%
Minor impact (1%-3% change) • 25%
Moderate impact (3%-5% change) • 25%
Major impact (more than 5% change) • 25%
Increase • 25%
Decrease • 25%
No significant change • 25%
Other • 25%
Stock price drop > 20% • 25%
Stock price drop ≤ 20% • 25%
No significant change • 25%
Stock price increase • 25%
Decrease by more than 5% • 25%
Decrease by 1% to 5% • 25%
No significant change (within ±1%) • 25%
Increase • 25%